We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rifampicin and Trimethoprim\Sulfamethoxazole plus intralesional antimony compared with antimony alone in treatment of cutaneous leishmaniasis.
- Authors
KAWEN, AHMED ABDULHUSSEIN; KATTOOF, WISAM MAJEED
- Abstract
The present study was conducted to evaluate the efficacy of Rifampicin and Trimethoprim plus sodium stibogluconate antimony and sodium stibogluconate antimony in treatment of cutaneous leishmaniasis. This study was carried out on 89 patients were enrolled in the study and were divided into two groups; group A included 43 patients treated with Rifampin and Trimethoprim plus sodium stibogluconate antimony of them 19 males and 24 females, while group B included 46 patients(24 males and 22 females) treated with sodium stibogluconate antimony, all were treated and evaluated weekly. The cure rate in complete response for patients in group A in six week 35(81.39%) and less rate was in one week 1(2.23%) when as compared with group B which recorded high rate in six week 31(67.39%) while did not show any response in one week. The highest rate of partial response was observed in the first week 16(37.20%) and then reduced in the third week 12(27.90%) and sixth week 7(16.27%) while the percentage of partial response in group B was reduced when as compared with group A. The present study recorded that the poor response of combination therapy in group A was 26(60.46%) in the first week then gradually reduced in third and sixth week 4(9.30%) and 1(2.32%) respectively while the poor response in group B was high especially in the first week 45(97.82%) and third week 20(43.47%).The present study showed that using adjunct drug such as Rifampin and Trimethoprim plus sodium stibogluconate antimony increase the therapeutic activity in treatment of cutaneous leishmaniasis when as compared with sodium stibogluconate antimony alone.
- Subjects
RIFAMPIN; CO-trimoxazole; ANTIMONY; CUTANEOUS leishmaniasis; DRUG efficacy
- Publication
International Journal of Pharmaceutical Research (09752366), 2019, Vol 11, Issue 2, p441
- ISSN
0975-2366
- Publication type
Article
- DOI
10.31838/ijpr/2019.11.02.074